These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9331111)

  • 1. Single-agent paclitaxel in advanced non-small cell lung cancer: single-center phase II study using a 3-hour administration schedule.
    Ranson MR; Jayson G; Perkins S; Anderson H; Thatcher N
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-6-S12-9. PubMed ID: 9331111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: a phase II trial.
    Gatzemeier U; Heckmayer M; Neuhauss R; Schlüter I; von Pawel J; Wagner H; Dreps A
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):24-8. PubMed ID: 8643966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-agent paclitaxel by 3-hour infusion in the treatment of non-small cell lung cancer: links between p53 and K-ras gene status and chemosensitivity.
    Rosell R; González-Larriba JL; Alberola V; Molina F; Monzó M; Benito D; Pérez JM; de Anta JM
    Semin Oncol; 1995 Dec; 22(6 Suppl 14):12-8. PubMed ID: 8553077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twice-weekly paclitaxel and radiation for stage III non-small cell lung cancer.
    Lau DH; Ryu JK; Gandara DR; Morgan R; Doroshow J; Wilder R; Leigh B
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-106-S12-109. PubMed ID: 9331132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary results of a phase I study of weekly paclitaxel infusion in patients with non-small cell lung cancer.
    Akerley W; Glantz M; Choy H
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):14-8. PubMed ID: 8941405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel and simultaneous radiation in the treatment of stage III A/B non-small cell lung cancer.
    Havemann K; Wolf M; Goerg C; Faoro C; Pfab R; Diergarten K
    Semin Oncol; 1995 Dec; 22(6 Suppl 14):19-22. PubMed ID: 8553078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: preliminary results comparing sequential phase II trials.
    DeVore RF; Jagasia M; Johnson DH
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-27-S12-29. PubMed ID: 9331116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized study.
    Kosmidis P; Mylonakis N; Fountzilas G; Samantas E; Athanassiadis A; Pavlidis N; Skarlos D
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-30-S12-33. PubMed ID: 9331117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network.
    Langer CJ; Millenson M; Rosvold E; Litwin S; McAleer CA; Bonjo CA; Ozols R
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-agent paclitaxel as a 3-hour infusion.
    Gatzemeier U; Neuhauss R; Schluter I; von Pawel J; Wagner H; Diergarten K
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):94-7. PubMed ID: 9007132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sequence-dependent paclitaxel/etoposide phase II trial in patients with non-small cell lung cancer.
    Rosell R; Felip E; Massuti B; González-Larriba JL; Benito D; López-Cabrerizo MP; Salamanca O; Camps C; Puerto-Pica J
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-56-S12-60. PubMed ID: 9331123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-escalation study of weekly 1-hour paclitaxel administration in patients with refractory cancer.
    Chang AY; Boros L; Asbury R; Hui L; Rubins J
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-69-S17-71. PubMed ID: 9374098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary results of a phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.
    Sørensen JB; Wedervang K; Dombernowsky P
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-18-S12-20. PubMed ID: 9331114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel (3-hour infusion) followed by carboplatin (24 hours after paclitaxel): a phase II study in advanced non-small cell lung cancer.
    Roychowdhury DF; Desai P; Zhu YW
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-37-S12-40. PubMed ID: 9331119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel and radiotherapy in the treatment of advanced non-small cell lung cancer.
    Marangolo M; Emiliani E; Rosti G; Giannini M; Vertogen B; Zumaglini F
    Semin Oncol; 1996 Dec; 23(6 Suppl 15):31-4. PubMed ID: 8996595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seven-week continuous-infusion paclitaxel plus concurrent radiation therapy for locally advanced non-small cell lung cancer: a phase I study.
    Rosenthal DI; Okani O; Corak J; Kavanaugh D; Kamen B; Vuitch FM; Gazdar AF; Greiner J; Frenkel EF; Carbone DP
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-96-S12-100. PubMed ID: 9331130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage weekly paclitaxel in recurrent ovarian cancer.
    Abu-Rustum NR; Aghajanian C; Barakat RR; Fennelly D; Shapiro F; Spriggs D
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II trial of weekly paclitaxel in patients with advanced lung cancer.
    Akerley W
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):55-8. PubMed ID: 9007123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-agent paclitaxel in the treatment of advanced non-small cell lung cancer.
    Socinski MA
    Oncologist; 1999; 4(5):408-16. PubMed ID: 10551557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.